Taiwan vaccine maker applies to conduct Phase 3 clinical trials in Paraguay
07/06/2021 09:47 PM
Taiwan's domestic COVID-19 vaccine producer Medigen Vaccine Biologics Corp. on Tuesday announced that it has officially applied to conduct Phase 3 clinical trials in Paraguay, Taiwan's only diplomatic ally in South America.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
Taiwan central bank raises 2025 GDP growth forecast to 4.55%
09/18/2025 10:58 PM - Politics
Taiwanese firm adopts drone inspired by Russia-Ukraine war experience
09/18/2025 10:42 PM - Politics
Taiwan showcases its indigenous, co-produced drones at Taipei expo
09/18/2025 10:18 PM - Politics
Weapons hot: Taipei defense expo showcases Taiwan's latest weaponry, drones
09/18/2025 09:26 PM - Politics
Indian space startups seek Taiwan defense partnerships at TADTE 2025
09/18/2025 09:25 PM